(Q48422544)

English

Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment.

scientific article published on 30 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

0 references

Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

1 reference

based on heuristic

inferred from title

4

object named as

William R Bishai

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

author name string

Geetha Srikrishna

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

Shashank Gupta

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

Kelly E Dooley

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

publication date

30 July 2015

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Future Microbiology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

10

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

1257-1260

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Acquired resistance of Mycobacterium tuberculosis to bedaquiline

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Verapamil increases the bactericidal activity of bedaquiline against Mycobacterium tuberculosis in a mouse model

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Systemic availability of oral verapamil and effect on PR interval in man

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.56

21 January 2018

Identifiers

10.2217/FMB.15.56

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/26226503

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48422544&oldid=1886752108"